328 related articles for article (PubMed ID: 37674169)
1. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis.
Kang W; Qiu X; Luo Y; Luo J; Liu Y; Xi J; Li X; Yang Z
J Transl Med; 2023 Sep; 21(1):598. PubMed ID: 37674169
[TBL] [Abstract][Full Text] [Related]
2. Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review.
Lu C; Shiradkar R; Liu Z
Chin J Cancer Res; 2021 Oct; 33(5):563-573. PubMed ID: 34815630
[TBL] [Abstract][Full Text] [Related]
3. The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy.
Banna GL; Olivier T; Rundo F; Malapelle U; Fraggetta F; Libra M; Addeo A
Front Med (Lausanne); 2019; 6():172. PubMed ID: 31417906
[TBL] [Abstract][Full Text] [Related]
4. Radiomic Models Predict Tumor Microenvironment Using Artificial Intelligence-the Novel Biomarkers in Breast Cancer Immune Microenvironment.
Lin G; Wang X; Ye H; Cao W
Technol Cancer Res Treat; 2023; 22():15330338231218227. PubMed ID: 38111330
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting.
Müller J; Leger S; Zwanenburg A; Suckert T; Lühr A; Beyreuther E; von Neubeck C; Krause M; Löck S; Dietrich A; Bütof R
Radiother Oncol; 2022 Apr; 169():96-104. PubMed ID: 35192909
[TBL] [Abstract][Full Text] [Related]
6. Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning.
Ye Z; Zeng D; Zhou R; Shi M; Liao W
Front Immunol; 2022; 13():819807. PubMed ID: 35603201
[TBL] [Abstract][Full Text] [Related]
7. Single‑cell multi‑omics advances in lymphoma research (Review).
Jin C; Zhou D; Li J; Bi L; Li L
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37615192
[TBL] [Abstract][Full Text] [Related]
8. Imaging Genomics and Multiomics: A Guide for Beginners Starting Radiomics-Based Research.
Singh S; Mohajer B; Wells SA; Garg T; Hanneman K; Takahashi T; AlDandan O; McBee MP; Jawahar A
Acad Radiol; 2024 Jan; ():. PubMed ID: 38286723
[TBL] [Abstract][Full Text] [Related]
9. Novel insights from spatial transcriptome analysis in solid tumors.
Du J; An ZJ; Huang ZF; Yang YC; Zhang MH; Fu XH; Shi WY; Hou J
Int J Biol Sci; 2023; 19(15):4778-4792. PubMed ID: 37781515
[TBL] [Abstract][Full Text] [Related]
10. The relationship between radiomics and pathomics in Glioblastoma patients: Preliminary results from a cross-scale association study.
Brancato V; Cavaliere C; Garbino N; Isgrò F; Salvatore M; Aiello M
Front Oncol; 2022; 12():1005805. PubMed ID: 36276163
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape.
Gui C; Wei J; Mo C; Liang Y; Cen J; Chen Y; Wang D; Luo J
Int J Biol Sci; 2023; 19(12):3951-3969. PubMed ID: 37564213
[No Abstract] [Full Text] [Related]
12. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients.
Wang R; Dai W; Gong J; Huang M; Hu T; Li H; Lin K; Tan C; Hu H; Tong T; Cai G
J Hematol Oncol; 2022 Jan; 15(1):11. PubMed ID: 35073937
[TBL] [Abstract][Full Text] [Related]
13. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
Su GH; Xiao Y; Jiang L; Zheng RC; Wang H; Chen Y; Gu YJ; You C; Shao ZM
J Transl Med; 2022 Oct; 20(1):471. PubMed ID: 36243806
[TBL] [Abstract][Full Text] [Related]
14. Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.
Kim K; Ku CR; Lee EJ
Endocrinol Metab (Seoul); 2023 Oct; 38(5):463-471. PubMed ID: 37828709
[TBL] [Abstract][Full Text] [Related]
15. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
[TBL] [Abstract][Full Text] [Related]
16. An immunometabolism subtyping system identifies S100A9
Bao X; Wang D; Dai X; Liu C; Zhang H; Jin Y; Tong Z; Li B; Tong C; Xin S; Li X; Wang Y; Liu L; Zhu X; Fu Q; Zheng Y; Deng J; Tian W; Guo T; Zhao P; Chen W; Fang W
Cell Rep Med; 2023 Apr; 4(4):100987. PubMed ID: 36990096
[TBL] [Abstract][Full Text] [Related]
17. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer.
Lv J; Ren J; Zheng J; Zhang F; Han M
Dis Markers; 2022; 2022():5621441. PubMed ID: 35242245
[TBL] [Abstract][Full Text] [Related]
19. Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning.
Li X; Yu X; Tian D; Liu Y; Li D
Med Phys; 2023 Nov; 50(11):7049-7059. PubMed ID: 37722701
[TBL] [Abstract][Full Text] [Related]
20. An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics.
Ma L; Peterson EA; Shin IJ; Muesse J; Marino K; Steliga MA; Atiq O; Arnaoutakis K; Wardell C; Wooldridge J; Prior F; Johann DJ
Front Genet; 2022; 13():987175. PubMed ID: 36846293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
